Details for Patent: 10,098,997
✉ Email this page to a colleague
Which drugs does patent 10,098,997 protect, and when does it expire?
Patent 10,098,997 protects HEPZATO and is included in one NDA.
This patent has twelve patent family members in seven countries.
Drugs Protected by US Patent 10,098,997
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delcath Systems Inc | HEPZATO | melphalan hydrochloride | POWDER;INTRA-ARTERIAL | 201848-001 | Aug 14, 2023 | RX | Yes | Yes | 10,098,997 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,098,997
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2776086 | ⤷ Subscribe | |||
| European Patent Office | 3241576 | ⤷ Subscribe | |||
| European Patent Office | 3590561 | ⤷ Subscribe | |||
| European Patent Office | 4242176 | ⤷ Subscribe | |||
| Spain | 2728280 | ⤷ Subscribe | |||
| Spain | 2750846 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
